GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
2,601.00
+7.95 (0.31%)
At close: Aug 10, 2026
BOM:500660 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹3,081. The average 1-year stock price forecast is 18.45% higher than the current stock price, while the lowest is ₹2,870 (+10.34%) and the highest is ₹3,500 (+34.56%).
Price Target: ₹3,081 (+18.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
42.53B
from 38.22B
Increased by 11.28%
Revenue Next Year
47.17B
from 42.53B
Increased by 10.91%
EPS This Year
68.53
from 60.11
Increased by 14.00%
EPS Next Year
78.88
from 68.53
Increased by 15.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.